172 related articles for article (PubMed ID: 33155905)
1. Properties of Ethnomedicinal Plants and Their Bioactive Compounds: Possible Use for COVID-19 Prevention and Treatment.
Shoaib A; Azmi L; Shukla I; Alqahtani SS; Alsarra IA; Shakeel F
Curr Pharm Des; 2021; 27(13):1579-1587. PubMed ID: 33155905
[TBL] [Abstract][Full Text] [Related]
2. Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: A review.
Adhikari B; Marasini BP; Rayamajhee B; Bhattarai BR; Lamichhane G; Khadayat K; Adhikari A; Khanal S; Parajuli N
Phytother Res; 2021 Mar; 35(3):1298-1312. PubMed ID: 33037698
[TBL] [Abstract][Full Text] [Related]
3. Anti-SARS-CoV-2 Potential of Artemisinins In Vitro.
Cao R; Hu H; Li Y; Wang X; Xu M; Liu J; Zhang H; Yan Y; Zhao L; Li W; Zhang T; Xiao D; Guo X; Li Y; Yang J; Hu Z; Wang M; Zhong W
ACS Infect Dis; 2020 Sep; 6(9):2524-2531. PubMed ID: 32786284
[TBL] [Abstract][Full Text] [Related]
4. Drug Discovery Strategies for SARS-CoV-2.
Shyr ZA; Gorshkov K; Chen CZ; Zheng W
J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
[TBL] [Abstract][Full Text] [Related]
5. In vitro efficacy of Artemisia extracts against SARS-CoV-2.
Nie C; Trimpert J; Moon S; Haag R; Gilmore K; Kaufer BB; Seeberger PH
Virol J; 2021 Sep; 18(1):182. PubMed ID: 34496903
[TBL] [Abstract][Full Text] [Related]
6. Phytotherapic Drugs for COVID-19 Treatment: A Scoping Review.
Singh M; Trivedi D; Mohapatra R; Bagchi T; Durthi CP; Kuppam C
Curr Pharm Des; 2021 Oct; 27(31):3389-3398. PubMed ID: 34225610
[TBL] [Abstract][Full Text] [Related]
7. Antiviral Essential Oils Incorporated in Nanocarriers: Strategy for Prevention from COVID-19 and Future Infectious Pandemics.
Kaur M; Devi G; Nagpal M; Singh M; Dhingra GA; Aggarwal G
Pharm Nanotechnol; 2020; 8(6):437-451. PubMed ID: 33069206
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
Goyal B; Goyal D
ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
[TBL] [Abstract][Full Text] [Related]
9. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
Froggatt HM; Heaton BE; Heaton NS
J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
[TBL] [Abstract][Full Text] [Related]
10. Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19.
Wijayasinghe YS; Bhansali P; Viola RE; Kamal MA; Poddar NK
Curr Pharm Des; 2021; 27(33):3526-3550. PubMed ID: 33213322
[TBL] [Abstract][Full Text] [Related]
11. Herbal Medicines to Fight Against COVID-19: New Battle with an Old Weapon.
Harwansh RK; Bahadur S
Curr Pharm Biotechnol; 2022; 23(2):235-260. PubMed ID: 33749558
[TBL] [Abstract][Full Text] [Related]
12. Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2.
Baggieri M; Gioacchini S; Borgonovo G; Catinella G; Marchi A; Picone P; Vasto S; Fioravanti R; Bucci P; Kojouri M; Giuseppetti R; D'Ugo E; Ubaldi F; Dallavalle S; Nuzzo D; Pinto A; Magurano F
Biomed Pharmacother; 2023 Dec; 168():115682. PubMed ID: 37832410
[TBL] [Abstract][Full Text] [Related]
13. COVID-19: Innovative Antiviral Drugs Required for Long-Term Prevention and Control of Coronavirus Diseases.
Ratcliffe NA; Castro HC; Paixão IC; Mello CB
Curr Med Chem; 2021; 28(18):3554-3567. PubMed ID: 33109030
[TBL] [Abstract][Full Text] [Related]
14. Shedding Light on the Effect of Natural Anti-Herpesvirus Alkaloids on SARS-CoV-2: A Treatment Option for COVID-19.
Hassan STS
Viruses; 2020 Apr; 12(4):. PubMed ID: 32340120
[TBL] [Abstract][Full Text] [Related]
15. Carbon-Based Nanomaterials: Promising Antiviral Agents to Combat COVID-19 in the Microbial-Resistant Era.
Serrano-Aroca Á; Takayama K; Tuñón-Molina A; Seyran M; Hassan SS; Pal Choudhury P; Uversky VN; Lundstrom K; Adadi P; Palù G; Aljabali AAA; Chauhan G; Kandimalla R; Tambuwala MM; Lal A; Abd El-Aziz TM; Sherchan S; Barh D; Redwan EM; Bazan NG; Mishra YK; Uhal BD; Brufsky A
ACS Nano; 2021 May; 15(5):8069-8086. PubMed ID: 33826850
[TBL] [Abstract][Full Text] [Related]
16. Natural Products as Potential Agents against SARS-CoV and SARSCoV- 2.
Raimundo E Silva JP; Acevedo CAH; de Souza TA; de Menezes RPB; Sessions ZL; Abreu LS; Cibulski SP; Scotti L; da Silva MS; Muratov EN; Scotti MT; Tavares JF
Curr Med Chem; 2021; 28(27):5498-5526. PubMed ID: 33550959
[TBL] [Abstract][Full Text] [Related]
17. Identification of herbal teas and their compounds eliciting antiviral activity against SARS-CoV-2 in vitro.
Le-Trilling VTK; Mennerich D; Schuler C; Sakson R; Lill JK; Kasarla SS; Kopczynski D; Loroch S; Flores-Martinez Y; Katschinski B; Wohlgemuth K; Gunzer M; Meyer F; Phapale P; Dittmer U; Sickmann A; Trilling M
BMC Biol; 2022 Nov; 20(1):264. PubMed ID: 36447206
[TBL] [Abstract][Full Text] [Related]
18. Plant Spices as a Source of Antimicrobial Synergic Molecules to Treat Bacterial and Viral Co-Infections.
Duarte NBA; Takahashi JA
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500303
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.
Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T
Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740
[TBL] [Abstract][Full Text] [Related]
20. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
Gudadappanavar AM; Benni J
J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
